Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities

被引:39
作者
Zimmermann, R
Hucha, A
Savoldelli, G
Binkert, F
Achermann, J
Grudzinskas, JG
机构
[1] UNIV HOSP,DEPT OBSTET,CH-8091 ZURICH,SWITZERLAND
[2] UNIV ZURICH,INST MED GENET,ZURICH,SWITZERLAND
[3] GENETICA,CYTOGENET LAB,ZURICH,SWITZERLAND
[4] LONDON HOSP,COLL MED,JOINT ACAD UNIT OBSTET GYNAECOL & REPROD PHYSIOL,LONDON,ENGLAND
来源
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1996年 / 103卷 / 10期
关键词
D O I
10.1111/j.1471-0528.1996.tb09552.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To assess the relation between serum parameters and nuchal translucency in pregnancies affected by fetal aneuploidy in the first trimester. Design Retrospective study of different serum parameters collected prior to chorionic villus sampling and measurement of nuchal translucency in relation to fetal aneuploidy. Setting Switzerland (German and Italian sector) and Bregenz, Austria. Population One thousand one hundred and fifty-one women aged 25 to 44 years at 10 to 13 weeks of gestation undergoing chorionic villus sampling, mostly for advanced maternal age. Fetal aneuploidy was found in 23 pregnancies including four cases of trisomy 21, five of trisomy 18 and one case of trisomy 13. Main outcome measure Fetal karyotype, serum levels of free beta-hCG, pregnancy-associated plasma protein A (PAPP-A) and alpha-fetoprotein and the measurement of nuchal translucency. Results Serum PAPP-A was decreased in all common chromosomal abnormalities. Free beta-hCG levels were increased in trisomy 21 but decreased in trisomy 18, whereas alpha-fetoprotein was low in trisomy 21, 18 and other chromosomal abnormalities. Nine of twenty-three abnormal embryos had evidence of an increased nuchal translucency. Nuchal translucency, however, did not seem to be associated with any alteration in the levels of the biochemical parameters in either chromosomally normal or abnormal embryos. A low serum PAPP-A or an increased nuchal translucency was seen in two-thirds of all pregnancies with chromosomal abnormalities. Conclusion A nuchal translucency greater than or equal to 3 mm and depressed serum PAPP-A levels have a good predictive value in the detection of fetal aneuploidy at 10 to 13 weeks of pregnancy. Serum free beta-hCG and alpha-fetoprotein levels may give additional information. An increased nuchal translucency was not associated with altered serum parameters. This would allow these different markers to be used in combination.
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 26 条
[1]   1ST-TRIMESTER BIOCHEMICAL SCREENING FOR FETAL CHROMOSOME-ABNORMALITIES AND NEURAL-TUBE DEFECTS [J].
AITKEN, DA ;
MCCAW, G ;
CROSSLEY, JA ;
BERRY, E ;
CONNOR, JM ;
SPENCER, K ;
MACRI, JN .
PRENATAL DIAGNOSIS, 1993, 13 (08) :681-689
[2]  
BARKAI G, 1987, LANCET, V2, P389
[3]   FIRST-TRIMESTER DOWNS-SYNDROME SCREENING USING NUCHAL TRANSLUCENCY - A PROSPECTIVE-STUDY IN PATIENTS UNDERGOING CHORIONIC VILLUS SAMPLING [J].
BRAMBATI, B ;
CISLAGHI, C ;
TULUI, L ;
ALBERTI, E ;
AMIDANI, M ;
COLOMBO, U ;
ZULIANI, G .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1995, 5 (01) :9-14
[4]   SERUM PAPP-A AND FREE BETA-HCG ARE FIRST-TRIMESTER SCREENING MARKERS FOR DOWN-SYNDROME [J].
BRAMBATI, B ;
TULUI, L ;
BONACCHI, I ;
SHRIMANKER, K ;
SUZUKI, Y ;
GRUDZINSKAS, JG .
PRENATAL DIAGNOSIS, 1994, 14 (11) :1043-1047
[5]  
BRAMBATI B, 1986, LANCET, V2, P165
[6]   LOW MATERNAL SERUM LEVELS OF PREGNANCY ASSOCIATED PLASMA PROTEIN-A (PAPP-A) IN THE 1ST TRIMESTER IN ASSOCIATION WITH ABNORMAL FETAL KARYOTYPE [J].
BRAMBATI, B ;
MACINTOSH, MCM ;
TEISNER, B ;
MAGUINESS, S ;
SHRIMANKER, K ;
LANZANI, A ;
BONACCHI, I ;
TULUI, L ;
CHARD, T ;
GRUDZINSKAS, JG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (04) :324-326
[7]  
BRAMBATI B, 1994, SCREENING DOWN SYNDR, P285
[8]   1ST-TRIMESTER MATERNAL SERUM BIOCHEMICAL INDICATORS IN DOWN SYNDROME [J].
BROCK, DJH ;
BARRON, L ;
HOLLOWAY, S ;
LISTON, WA ;
HILLIER, SG ;
SEPPALA, M .
PRENATAL DIAGNOSIS, 1990, 10 (04) :245-251
[9]  
CHARD T, 1991, EMBRYO NORMAL ABNORM, P181
[10]   MATERNAL SERUM SCREENING FOR ALPHA-FETOPROTEIN, UNCONJUGATED ESTRIOL, AND HUMAN CHORIONIC-GONADOTROPIN BETWEEN 11 AND 15 WEEKS OF PREGNANCY TO DETECT FETAL CHROMOSOME-ABNORMALITIES [J].
CRANDALL, BF ;
HANSON, FW ;
KEENER, S ;
MATSUMOTO, M ;
MILLER, W .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (06) :1864-1869